EU Commission facilitates faster access to medicines for joint clinical assessments
The European Commission adopted new rules for the joint clinical assessments of medicines at Union level, contributing to faster access to medicines for EU patients. These new rules define the timelines and the steps for conducting EU joint clinical assessments.